EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Citron Pharma LLC, announced today that it is the recipient of a 2014 Distribution Industry Award of Notable Achievements (DIANA) awarded by the Healthcare Distribution Management Association (HDMA). Citron was presented with the DIANA for “Best New Generic Product Introduction” for the launch of Duloxetine Delayed-Release Capsules. Citron Pharma was honored with one of the ten DIANA awards presented at the 2014 HDMA Business and Leadership Conference in Phoenix, Arizona on June 2, 2014.
Commenting on the award, Karen Strelau, EVP, Sales and Marketing of Citron Pharma said, “We are honored by the recognition that Citron received from the HDMA.” Ms. Strelau added, “This is very exciting considering that Citron is an up and coming new company. This award reflects our unwavering commitment to excellence and collaborative relationships as we manage our phenomenal growth in the industry.”
The DIANA awards have been presented by the HDMA for over 50 years to consumer and pharmaceutical manufacturers, who set the standard of excellence throughout the healthcare industry. The distributor members of HDMA cast their votes based on various criteria and ultimately choose the winners of these coveted awards. Citron Pharma is honored to stand in the winner’s circle with all the past recipients who have shown innovation and leadership throughout the industry.
Ira Baeringer, EVP, Contracts, Pricing & Business Development, further remarked, “As a new entrant to the market, we purposely set the bar high and are happy to receive HDMA’s recognition for our performance. While we celebrate this achievement, our team of talented employees is rededicated to provide the same high level of service across the many new products coming from our pipeline.”
CITRON PHARMA LLC
Citron Pharma is a privately held pharmaceutical company, focused on developing and marketing both branded and generic products from diverse therapy segments. Citron’s multi-therapy focus brings a wide portfolio of vital products to the market from the best of FDA-approved manufacturing facilities in India and the USA. For more Information on Citron, please visit www.citronpharma.com.
HDMA is the national association representing primary healthcare distributors, the vital link between the nation’s pharmaceutical manufacturers and healthcare providers. Each business day, HDMA member companies ensure that nine million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation’s healthcare system.